Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer
Claudia Tulotta, Diane V. Lefley, C. Moore, et al.
npj Breast Cancer (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Immunotherapeutic Effect of Photothermal-Mediated Exosomes Secreted From Breast Cancer Cells
Meysam Najaflou, Farhad Bani, Ahmad Yari Khosroushahi
Nanomedicine (2023) Vol. 18, Iss. 22, pp. 1535-1552
Closed Access | Times Cited: 6
Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism
Yiqi Zhao, Hao Jia, Xiumeng Hua, et al.
Current Cardiology Reports (2023) Vol. 25, Iss. 8, pp. 863-878
Open Access | Times Cited: 4
Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone Metastasis
Jiabao Zhou, Jennifer M. Down, Christopher N. George, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4816-4816
Open Access | Times Cited: 7
Immunogenic cell death-related classifications in breast cancer identify precise immunotherapy biomarkers and enable prognostic stratification
Xue Wang, Hailiang Huang, Xijian Liu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 7
Breast biomarkers for the detection of malignancy in benign diseases in women
А. А. Студеникина, С. А. Архипов, Н. А. Вараксин, et al.
Russian Journal of Preventive Medicine (2024) Vol. 27, Iss. 1, pp. 63-63
Closed Access | Times Cited: 1
Secreted clusterin inhibits tumorigenesis by modulating tumor cells and macrophages in human meningioma
Chao Ke, Boya Huang, Xiang Jian, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 7, pp. 1262-1279
Closed Access | Times Cited: 1
Effect of 2‐methoxyestradiol on mammary tumor initiation and progression
Kimberly T. Peta, Chrisna Durandt, Marlene B. van Heerden, et al.
Cancer Reports (2024) Vol. 7, Iss. 4
Open Access | Times Cited: 1
Disrupted Lipid Metabolism, Cytokine Signaling, and Dormancy: Hallmarks of Doxorubicin-Resistant Triple-Negative Breast Cancer Models
Radhakrishnan Vishnubalaji, Nehad M. Alajez
Cancers (2024) Vol. 16, Iss. 24, pp. 4273-4273
Open Access | Times Cited: 1
Muscle and Bone Defects in Metastatic Disease
Martina Pauk, Hiroaki Saito, Eric Hesse, et al.
Current Osteoporosis Reports (2022) Vol. 20, Iss. 5, pp. 273-289
Open Access | Times Cited: 3
Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery
Olha Kholod, William Basket, Jonathan B. Mitchem, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5806-5806
Open Access | Times Cited: 3
Disulfidptosis-related prognostic model based on multiomics and the significance of IL1B in ovarian cancer
Kunyu Wang, Bin Li
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity
Sofia Morazzo, Soraia Fernandes, Marina Fortea, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Postoperative Immunosuppression Following Breast-Conserving Surgery vs. Mastectomy: The Role of Surgical Injuries and Intraoperative Sympathetic Activation
Hamid Raza, Ayesha Inam, Nadir R. Farid, et al.
Pakistan Journal of Health Sciences (2024), pp. 150-154
Closed Access
Immunotherapy in the Fight Against Bone Metastases: A Review of Recent Developments and Challenges
Zhao-Yang Peng, Wei Huang, Ziyu Xiao, et al.
Current Treatment Options in Oncology (2024)
Open Access
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasis
Karan M. Shah, Luke Tattersall, Aleana Hussain, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
IL1β Expression Driven by Androgen Receptor Absence or Inactivation Promotes Prostate Cancer Bone Metastasis
Anthony DiNatale, Asurayya Worrede, Waleed Iqbal, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 12, pp. 1545-1557
Open Access | Times Cited: 2
The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation
Raylane A. G. Cambui, Fernanda Pereira Fernandes, Vinícius Nunes Cordeiro Leal, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Involvement of the p38 MAPK-NLRC4-Caspase-1 Pathway in Ionizing Radiation-Enhanced Macrophage IL-1β Production
Ji Sue Baik, You Na Seo, Young‐Choon Lee, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13757-13757
Open Access | Times Cited: 1
The Role of Inflammasome in Cancers and Potential Therapeutic Targets
Pooya Farhangnia, Amir Reza Safdarian, Mahzad Akbarpour
Springer eBooks (2023), pp. 1-42
Closed Access
Selective inhibition of fibroblast-specific Domain Discoidin Receptor 1 (DDR1) reduces collagen deposition and modulates fibroblast-specific cytokine release within the breast microenvironment
Daniel Fein, Nicole Traugh, Gat Rauner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Previous Page - Page 2

Scroll to top